|
1
|
Torres CR and Hart GW: Topography and
polypeptide distribution of terminal N-acetylglucosamine residues
on the surfaces of intact lymphocytes. Evidence for O-linked
GlcNAc. J Biol Chem. 259:3308–3317. 1984.PubMed/NCBI
|
|
2
|
Holt GD and Hart GW: The subcellular
distribution of terminal N-acetylglucosamine moieties. Localization
of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol
Chem. 261:8049–8057. 1986.PubMed/NCBI
|
|
3
|
Paria BC, Huet-Hudson YM and Dey SK:
Blastocyst's state of activity determines the ‘window’ of
implantation in the receptive mouse uterus. Proc Natl Acad Sci USA.
90:10159–10162. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoshinaga K: Uterine receptivity for
blastocyst implantation. Ann N Y Acad Sci. 541:424–431. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Psychoyos A: Hormonal control of
ovoimplantation. Vitam Horm. 31:201–256. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim HJ and Dey SK: HB-EGF: A unique
mediator of embryo-uterine interactions during implantation. Exp
Cell Res. 315:619–626. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu J, Fan J, Xu Y, Xie Y, Gong T and Kong
Y: Regulatory function of β1, 4-galac tosyltransferase I expression
on Lewis-Y glycan and embryo implantation. Gene. 562:220–225. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu J, Sui LL, Cui D, Ma YN, Zhu CY and
Kong Y: Effects of LeY glycan expression on embryo implantation.
Eur Rev Med Pharmacol Sci. 20:3327–3335. 2016.PubMed/NCBI
|
|
9
|
Slawson C, Pidala J and Potter R:
Increased N-acetyl-beta- glucosaminidase activity in primary breast
carcinomas corresponds to a decrease in N-acetylglucosamine
containing proteins. Biochim Biophys Acta. 1537:147–157. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murray MJ and Lessey BA: Embryo
implantation and tumor metastasis: Common pathways of invasion and
angiogenesis. Semin Reprod Endocrinol. 17:275–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hannan NJ, Paiva P, Dimitriadis E and
Salamonsen LA: Models for study of human embryo implantation:
Choice of cell lines? Biol Reprod. 82:235–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2018. View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma XH, Hu SJ, Yu H, Xu LB and Yang ZM:
Differential expression of transcriptional repressor snail gene at
implantation site in mouse uterus. Mol Reprod Dev. 73:133–141.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dey SK, Lim H, Das SK, Reese J, Paria BC,
Daikoku T and Wang H: Molecular cues to implantation. Endocr Rev.
25:341–373. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin XM: Signal transduction mediated by
Bid, a pro-death Bcl-2 family proteins, connects the death receptor
and mitochondria apoptosis pathways. Cell Res. 10:161–167. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dennis JW, Nabi IR and Demetriou M:
Metabolism, cell surface organization, and disease. Cell.
139:1229–1241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Queiroz RM, Carvalho E and Dias WB:
O-GlcNAcylation: The sweet side of the cancer. Front Oncol.
4:1322014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marshall S, Bacote V and Traxinger RR:
Discovery of a metabolic pathway mediating glucose-induced
desensitization of the glucose transport system. Role of hexosamine
biosynthesis in the induction of insulin resistance. J Biol Chem.
266:4706–4712. 1991.PubMed/NCBI
|
|
21
|
Wells L, Vosseller K and Hart GW: A role
for N-acetylglucosamine as a nutrient sensor and mediator of
insulin resistance. Cell Mol Life Sci. 60:222–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee TI and Young RA: Transcriptional
regulation and its misregulation in disease. Cell. 152:1237–1251.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koo CY, Muir KW and Lam EW: FOXM1: From
cancer initiation to progression and treatment. Biochim Biophys
Acta. 1819:28–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khan Z and Bisen PS: Oncoapoptotic
signaling and deregulated target genes in cancers: Special
reference to oral cancer. Biochim Biophys Acta. 1836:123–145.
2013.PubMed/NCBI
|
|
25
|
Krzeslak A, Pomorski L and Lipinska A:
Elevation of nucleocytoplasmic beta-N-acetylglucosaminidase
(O-GlcNAcase) activity in thyroid cancers. Int J Mol Med.
25:643–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C,
Yang J, Han F, Lu X and Yu W: GlcNAcylation plays an essential role
in breast cancer metastasis. Cancer Res. 70:6344–6351. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X,
Cong Q and Yu W: O-GlcNAcylation is a novel regulator of lung and
colon cancer malignancy. Biochim Biophys Acta. 1812:514–519. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi Y, Tomic J, Wen F, Shaha S, Bahlo A,
Harrison R, Dennis JW, Williams R, Gross BJ, Walker S, et al:
Aberrant O-GlcNAcylation characterizes chronic lymphocytic
leukemia. Leukemia. 24:1588–1598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shafi R, Iyer SP, Ellies LG, O'Donnell N,
Marek KW, Chui D, Hart GW and Marth JD: The O-GlcNAc transferase
gene resides on the X chromosome and is essential for embryonic
stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA.
97:5735–5739. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jang H, Kim TW, Yoon S, Choi SY, Kang TW,
Kim SY, Kwon YW, Cho EJ and Youn HD: O-GlcNAc regulates
pluripotency and reprogramming by directly acting on core
components of the pluripotency network. Cell Stem Cell. 11:62–74.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lefebvre T, Pinte S, Guérardel C, Deltour
S, Martin-Soudant N, Slomianny MC, Michalski JC and Leprince D: The
tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc
glycosylated. Eur J Biochem. 271:3843–3854. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tai HC, Khidekel N, Ficarro SB, Peters EC
and Hsieh-Wilson LC: Parallel identification of O-GlcNAc-modified
proteins from cell lysates. J Am Chem Soc. 126:10500–10501. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schlummer S, Vetter R, Kuder N, Henkel A,
Chen YX, Li YM, Kuhlmann J and Waldmann H: Influence of serine
O-glycosylation or O-phosphorylation close to the vJun nuclear
localisation sequence on nuclear import. Chembiochem. 7:88–97.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Teng CB, Diao HL, Ma XH, Xu LB and Yang
ZM: Differential expression and activation of Stat3 during mouse
embryo implantation and decidualization. Mol Reprod Dev. 69:1–10.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cameron AM, Lawless SJ and Pearce EJ:
Metabolism and acetylation in innate immune cell function and fate.
Semin Immunol. 28:408–416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hart GW, Housley MP and Slawson C: Cycling
of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.
Nature. 446:1017–1022. 2007. View Article : Google Scholar : PubMed/NCBI
|
